Trials / Unknown
UnknownNCT02639858
Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC
A Phase II Study to Evaluate the Efficacy and Safety of Docetaxel-PM in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 31 (estimated)
- Sponsor
- Samyang Biopharmaceuticals Corporation · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
A phase II study to evaluate the efficacy and safety of Docetaxel-PM in recurrent or metastatic head and neck squamous cell carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Docetaxel-PM | Docetaxel PM 75mg/m2 IV infusion |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2020-09-01
- Completion
- 2020-09-01
- First posted
- 2015-12-28
- Last updated
- 2017-05-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02639858. Inclusion in this directory is not an endorsement.